Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoyuki Sakamoto

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Medical Oncology (Northwood, London, England)|May 29, 2019
Clinical significance of soluble forms of immune checkpoint molecules in advanced esophageal cancerJuichiro Yoshida, Takeshi Ishikawa, Toshifumi Doi, et al.
Oncology Reports|July 7, 2020
Metformin inhibits TGF‑β1‑induced epithelial‑mesenchymal transition and liver metastasis of pancreatic cancer cellsJuichiro Yoshida, Takeshi Ishikawa, Yuki Endo, et al.
Oncology Reports|April 17, 2013
Anoxia/reoxygenation induces epithelial-mesenchymal transition in human colon cancer cell linesManabu Okajima, Satoshi Kokura, Takeshi Ishikawa, et al.
Journal of Clinical Biochemistry and Nutrition|February 3, 2025
The association between serum zinc level and clinical features in patients with inflammatory bowel diseaseTatsushi Omatsu, Tomohisa Takagi, Takeshi Yasuda, et al.
Oncology Reports|July 5, 2016
The amino acid-rich elemental diet Elental® preserves lean body mass during chemo- or chemoradiotherapy for esophageal cancerTakeshi Ishikawa, Tomoyo Yasuda, Toshifumi Doi, et al.
Journal of Clinical Biochemistry and Nutrition|August 15, 2014
The inhibitory effect of heat treatment against epithelial-mesenchymal transition (EMT) in human pancreatic adenocarcinoma cell linesReiko Kimura-Tsuchiya, Takeshi Ishikawa, Satoshi Kokura, et al.
International Journal of Cancer|February 2, 2018
Phase I clinical trial of adoptive transfer of expanded natural killer cells in combination with IgG1 antibody in patients with gastric or colorectal cancerTakeshi Ishikawa, Tetsuya Okayama, Naoyuki Sakamoto, et al.
International Journal of Cancer|May 29, 2015
Tumor inoculation site affects the development of cancer cachexia and muscle wastingTatsuzo Matsuyama, Takeshi Ishikawa, Tetsuya Okayama, et al.
International Journal of Cancer|February 20, 2013
Whole blood interferon-γ levels predict the therapeutic effects of adoptive T-cell therapy in patients with advanced pancreatic cancerTakeshi Ishikawa, Satoshi Kokura, Naoyuki Sakamoto, et al.
Clinical Biochemistry|October 4, 2011
Relationship between circulating cytokine levels and physical or psychological functioning in patients with advanced cancerTakeshi Ishikawa, Satoshi Kokura, Naoyuki Sakamoto, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Medical Oncology (Northwood, London, England)|May 29, 2019
Clinical significance of soluble forms of immune checkpoint molecules in advanced esophageal cancerJuichiro Yoshida, Takeshi Ishikawa, Toshifumi Doi, et al.
Oncology Reports|July 7, 2020
Metformin inhibits TGF‑β1‑induced epithelial‑mesenchymal transition and liver metastasis of pancreatic cancer cellsJuichiro Yoshida, Takeshi Ishikawa, Yuki Endo, et al.
Oncology Reports|April 17, 2013
Anoxia/reoxygenation induces epithelial-mesenchymal transition in human colon cancer cell linesManabu Okajima, Satoshi Kokura, Takeshi Ishikawa, et al.
Journal of Clinical Biochemistry and Nutrition|February 3, 2025
The association between serum zinc level and clinical features in patients with inflammatory bowel diseaseTatsushi Omatsu, Tomohisa Takagi, Takeshi Yasuda, et al.
Oncology Reports|July 5, 2016
The amino acid-rich elemental diet Elental® preserves lean body mass during chemo- or chemoradiotherapy for esophageal cancerTakeshi Ishikawa, Tomoyo Yasuda, Toshifumi Doi, et al.
Journal of Clinical Biochemistry and Nutrition|August 15, 2014
The inhibitory effect of heat treatment against epithelial-mesenchymal transition (EMT) in human pancreatic adenocarcinoma cell linesReiko Kimura-Tsuchiya, Takeshi Ishikawa, Satoshi Kokura, et al.
International Journal of Cancer|February 2, 2018
Phase I clinical trial of adoptive transfer of expanded natural killer cells in combination with IgG1 antibody in patients with gastric or colorectal cancerTakeshi Ishikawa, Tetsuya Okayama, Naoyuki Sakamoto, et al.
International Journal of Cancer|May 29, 2015
Tumor inoculation site affects the development of cancer cachexia and muscle wastingTatsuzo Matsuyama, Takeshi Ishikawa, Tetsuya Okayama, et al.
International Journal of Cancer|February 20, 2013
Whole blood interferon-γ levels predict the therapeutic effects of adoptive T-cell therapy in patients with advanced pancreatic cancerTakeshi Ishikawa, Satoshi Kokura, Naoyuki Sakamoto, et al.
Clinical Biochemistry|October 4, 2011
Relationship between circulating cytokine levels and physical or psychological functioning in patients with advanced cancerTakeshi Ishikawa, Satoshi Kokura, Naoyuki Sakamoto, et al.
Pageof 4